ES8602582A1 - Un procedimiento para la preparacion de arilindan-1,3-dionas. - Google Patents

Un procedimiento para la preparacion de arilindan-1,3-dionas.

Info

Publication number
ES8602582A1
ES8602582A1 ES536743A ES536743A ES8602582A1 ES 8602582 A1 ES8602582 A1 ES 8602582A1 ES 536743 A ES536743 A ES 536743A ES 536743 A ES536743 A ES 536743A ES 8602582 A1 ES8602582 A1 ES 8602582A1
Authority
ES
Spain
Prior art keywords
halo
alkoxy
diarylindane
diones
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES536743A
Other languages
English (en)
Other versions
ES536743A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of ES536743A0 publication Critical patent/ES536743A0/es
Publication of ES8602582A1 publication Critical patent/ES8602582A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33—Polycyclic acids
    • C07C63/331—Polycyclic acids with all carboxyl groups bound to non-condensed rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
    • C07C49/67—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/39—Unsaturated compounds containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pens And Brushes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE ARILINDAN-1,3-DIONAS DE FORMULA (I). CONSISTE EN SOMETER A REACCION DE TRANSPOSICION UN COMPUESTO DE FORMULA (II) DONDE W REPRESENTA UN RADICAL -COOO-C CH-AR1, SEGUIDO DE HALOGENACION DEL COMPUESTO ASI OBTENIDO. OPCIONALMENTE SE PUEDE SOMETER A UN PROCESO DE HIDROLISIS, SEGUIDO DE UNA CONVERSION EN UNA SAL FARMACEUTICA DEL MISMO. EN EL COMPUESTO (I) LOS AR1 Y AR2 SON GRUPOS FENILO O NAFTILO SUSTITUIDOS O NO. APLICADO EN EL TRATAMIENTO DE LA INFLAMACION, LA PSORIASIS Y EL ASMA.
ES536743A 1983-10-14 1984-10-11 Un procedimiento para la preparacion de arilindan-1,3-dionas. Expired ES8602582A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838327598A GB8327598D0 (en) 1983-10-14 1983-10-14 Pharmacologically active diarylindane-13-diones

Publications (2)

Publication Number Publication Date
ES536743A0 ES536743A0 (es) 1985-11-16
ES8602582A1 true ES8602582A1 (es) 1985-11-16

Family

ID=10550228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536743A Expired ES8602582A1 (es) 1983-10-14 1984-10-11 Un procedimiento para la preparacion de arilindan-1,3-dionas.

Country Status (16)

Country Link
US (1) US4569945A (es)
EP (1) EP0138272B1 (es)
JP (1) JPS60109541A (es)
KR (1) KR920003101B1 (es)
AT (1) ATE32214T1 (es)
AU (1) AU561309B2 (es)
CA (1) CA1245232A (es)
DE (1) DE3469020D1 (es)
DK (1) DK491984A (es)
ES (1) ES8602582A1 (es)
FI (1) FI82923C (es)
GB (1) GB8327598D0 (es)
GR (1) GR80629B (es)
HU (1) HUT35627A (es)
PT (1) PT79356B (es)
ZA (1) ZA847967B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556966B1 (fr) * 1983-12-26 1987-09-25 Bouchard Sa Laboratoires Nouvelle application therapeutique d'un derive de l'indane dione et les compositions pharmaceutiques destinees a cet usage
FR2593501B1 (fr) * 1986-01-29 1988-05-06 Panmedica Sa Nouveaux derives bis (r-oxyimino)-5,7 dihydro-6,7 (5h) dibenzo (a,c) cycloheptene, leurs procedes de preparation et leur application comme medicaments
JP2582898B2 (ja) * 1989-05-16 1997-02-19 三菱化学株式会社 インダン―１，３―ジオン誘導体およびこれを有効成分とする除草剤
US9346749B2 (en) * 2011-06-16 2016-05-24 Korea Research Institute Of Chemical Technology 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
EP2933254B1 (en) 2012-12-14 2021-01-20 Korea Research Institute of Chemical Technology Novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
TWI832045B (zh) 2020-04-20 2024-02-11 瑞士商諾華公司 抗病毒性1,3-二氧代茚化合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2361517A (en) * 1939-09-22 1944-10-31 Gen Electric Sealing apparatus
DE947473C (de) * 1953-04-30 1956-08-16 Geigy Ag J R Verfahren zur Herstellung von 2-(p-Chlorphenyl)-indan-1, 3-dion
DE1130439B (de) * 1960-06-27 1962-05-30 Us Vitamin Pharm Corp Verfahren zur Herstellung von 2-Arylindandionen
NL128364C (es) * 1964-08-27
GB1172696A (en) * 1966-10-20 1969-12-03 Koninklijke Pharma Fab Nv Phenyl-Indandione Derivatives
US3784606A (en) * 1968-08-29 1974-01-08 Pfizer Novel 2-aryl-1,3-indandiones and 2-aryl-2,3-dihydrobenz(f)indene-1,3-diones
US3879468A (en) * 1969-04-14 1975-04-22 Union Carbide Corp 2-(poly substituted phenyl)-1,3-indandione compounds
US3803240A (en) * 1969-04-14 1974-04-09 Union Carbide Corp 2-(2,6-substituted-phenyl)-1,3-indandiones
US3784605A (en) * 1971-05-13 1974-01-08 Union Carbide Corp 2-(polysubstituted phenyl)-1,3-indandione compounds
GB1380089A (en) * 1972-01-20 1975-01-08 Istituto Gentilipisa Spa 2-aryl-1,3-indandiones
US3978231A (en) * 1972-01-25 1976-08-31 Beecham Group Limited Pharmaceutical compositions and method of treating allergic conditions utilizing 2-nitroindane-1,3-dione derivatives as the active agents
US3976681A (en) * 1973-10-12 1976-08-24 Merck & Co., Inc. [1,3-Dioxo-2-substituted and 2,2-disubstituted- indanyloxy (or thio] alkanoic acids
FR2392951A2 (fr) * 1975-02-07 1978-12-29 Creat Lab Nouveaux derives de la ninhydrine, leurs procedes de preparation et medicaments contenant ces derives

Also Published As

Publication number Publication date
DE3469020D1 (en) 1988-03-03
HUT35627A (en) 1985-07-29
DK491984D0 (da) 1984-10-12
FI82923B (fi) 1991-01-31
EP0138272B1 (en) 1988-01-27
JPS60109541A (ja) 1985-06-15
AU3418484A (en) 1985-04-18
KR850003382A (ko) 1985-06-17
FI844020L (fi) 1985-04-15
FI82923C (fi) 1991-05-10
FI844020A0 (fi) 1984-10-12
PT79356B (en) 1986-09-08
PT79356A (en) 1984-11-01
ATE32214T1 (de) 1988-02-15
ES536743A0 (es) 1985-11-16
EP0138272A1 (en) 1985-04-24
US4569945A (en) 1986-02-11
GB8327598D0 (en) 1983-11-16
DK491984A (da) 1985-04-15
ZA847967B (en) 1985-05-29
CA1245232A (en) 1988-11-22
KR920003101B1 (ko) 1992-04-18
AU561309B2 (en) 1987-05-07
GR80629B (en) 1985-02-12

Similar Documents

Publication Publication Date Title
DK193584A (da) Naphthoquinonderivater
DE3683175D1 (de) Azolylmethyloxirane - ihre herstellung und verwendung als pflanzenschutzmittel.
NZ297157A (en) Amine derivatives with calcium ion receptor activity; medicaments containing such compounds
ES8601878A1 (es) Procedimiento para preparar nuevas 1-bencil-aminoalquil-pi- rrolidinonas
ES525653A0 (es) Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
ES8602582A1 (es) Un procedimiento para la preparacion de arilindan-1,3-dionas.
DE3682032D1 (de) Propylamine, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ES533355A0 (es) Procedimiento para la preparacion de derivados de 1-(fenil)-1-hidroxi-2-amino-3-fluoro-propano
EP0130366A3 (en) Arylalkylimidazolium and triazolium salts, process for their preparation and their use as microbicides
GB1516539A (en) Tertiary amino alkyl phenyl ether compounds and their use as anesthetics
DK152580C (da) Ammelinium-beta-octamolybdat og dets anvendelse som roeghaemmende additiv
ES8601095A1 (es) Un metodo de preparar derivados de 4-diisobutilaminoetanol
ES8603446A1 (es) Procedimiento para preparar la n-(3-trifluorometilfenil)-n'-propargil-piperazina
PT80781B (pt) Processo para a preparacao de novos derivados de oxaazafosforina
ES8604532A1 (es) Procedimiento de preparacion de nuevos derivados as-triazinos condensados
ES8105271A1 (es) Procedimiento para la obtencion de anilidas de acido ciclo- alcan (alquen) carboxilico,de efecto fungicida
SE8301263L (sv) Nya 3-azetidinyletyl-1-fenyl-2-imidazolidinonderivat och deras anvendning som neuroleptiska medel
FR2228779A1 (en) (4-Phenylpiperazino) alkyl esters - with analgesic activity for human and veterinary use
FR2226163A2 (en) 2-Amino-5-methyl-4-phenyl-1-pyrrolines - with antidepressant and antiarrhythmic activity
NO953962L (no) Fremgangsmåte for bekjempelse av bakterievekst i oljefeltutstyr
ES381207A1 (es) Un procedimiento para preparar nuevas 1,2-difenil-3,5-dioxo-pirazolidinas sustituidas en la posicion 4.
ES8800930A1 (es) Un metodo de preparacion de un compuesto de oxodiazina
ES2041649T3 (es) Medicamentos antibacterianos para peces.
FR2251267A1 (en) Herbicidal compsns. - contg. 3-cyclo hexyl-5,6-trimethylene -uracil and 3-carbamoyloxy-acylanilines
FR2104648A1 (en) N-(phenyl-cyclohexyl) salicylamides - analgesics, antipyretics antiinflammatories etc

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303